Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

biliary tract cancer

  • Open Access
    Preoperative Psoas Muscle Thickness to Height Ratio Predicts Poor Survival After Resection of Biliary Tract Cancer
    SHINICHI IKUTA, TSUKASA AIHARA, TAKAYOSHI NAKAJIMA, MEIDAI KASAI and NAOKI YAMANAKA
    In Vivo March 2023, 37 (2) 879-886; DOI: https://doi.org/10.21873/invivo.13156
  • You have access
    Prognostic Impact of Sarcopenia in Patients With Biliary Tract Cancer Undergoing Chemotherapy
    KOKI MEGURO, KUNIHIRO HOSONO, MOTOKAZU SATO, YUICHI SUGIMOTO, YUSUKE TAKAI, YUSUKE KURITA, KENJI KANOSHIMA, TOMOKI SHIMIZU, EIJI SAKAI and ATSUSHI NAKAJIMA
    In Vivo September 2021, 35 (5) 2909-2915; DOI: https://doi.org/10.21873/invivo.12581
  • You have access
    ATM Expression as a Prognostic Marker in Patients With Advanced Biliary Tract Cancer Treated With First-line Gemcitabine and Platinum Chemotherapy
    HYERA KIM, SEUNG TAE KIM, KWAI HAN YOO, JUNG YONG HONG, YOUNG SUK PARK, HO YEONG LIM and JOON OH PARK
    In Vivo January 2021, 35 (1) 499-505; DOI: https://doi.org/10.21873/invivo.12284
  • You have access
    Biomarker Analyses in Patients With Advanced Solid Tumors Treated With the LAT1 Inhibitor JPH203
    NAOHIRO OKANO, KIYOMI HANA, DAISUKE NARUGE, KIRIO KAWAI, TAKAAKI KOBAYASHI, FUMIO NAGASHIMA, HITOSHI ENDOU and JUNJI FURUSE
    In Vivo September 2020, 34 (5) 2595-2606; DOI: https://doi.org/10.21873/invivo.12077
  • You have access
    The ABO Blood Group Impacts the Survival of Patients Undergoing Pancreatoduodenectomy for Biliary Tract Cancer
    SHOZO MORI, TAKU AOKI, KAZUMA TAGO, TAKAYUKI SHIMIZU, NOBUHIRO HARADA, KYUNG-HWA PARK, YUHKI SAKURAOKA, TAKAYUKI SHIRAKI, YUKIHIRO ISO and KEIICHI KUBOTA
    In Vivo July 2020, 34 (4) 1893-1900; DOI: https://doi.org/10.21873/invivo.11985
  • You have access
    Anti-EGFR Monoclonal Antibodies in Advanced Biliary Tract Cancer: A Systematic Review and Meta-analysis
    ALESSANDRO RIZZO, GIORGIO FREGA, ANGELA DALIA RICCI, ANDREA PALLONI, FRANCESCA ABBATI, STEFANIA DE LORENZO, MARZIA DESERTI, SIMONA TAVOLARI and GIOVANNI BRANDI
    In Vivo March 2020, 34 (2) 479-488; DOI: https://doi.org/10.21873/invivo.11798
  • You have access
    5-Aminolevulinic-acid-mediated Photodynamic Diagnosis Enhances the Detection of Peritoneal Metastases in Biliary Tract Cancer in Mice
    TOSHIHIRO KUSHIBIKI, TAKEHIRO NOJI, YUMA EBIHARA, KOJI HONTANI, MASATO ONO, SHOTA KUWABARA, TORU NAKAMURA, TAKAHIRO TSUCHIKAWA, KEISUKE OKAMURA, MASAHIRO ISHIZUKA and SATOSHI HIRANO
    In Vivo September 2017, 31 (5) 905-908;
In Vivo

© 2025 In Vivo

Powered by HighWire